Skip to content

Clinical trials

Rhabdomyosarcoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Country / region: Spain Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20132
20141
20151
20181
20191
20202
20212
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Eli Lilly and Company2
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Celgene1
Eisai Inc.1
GlaxoSmithKline1
Grupo Espanol de Investigacion en Sarcomas1
ITM Solucin GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma16
Sarcoma8
Sarcoma, Ewing8
Neuroblastoma6
Neoplasms5
Fibrosarcoma4
Leiomyosarcoma4
Osteosarcoma4
Sarcoma, Synovial4
Diffuse Intrinsic Pontine Glioma3

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.